0
0
Read Time:14 Second
MUMBAI: Viatris Inc., the result of the merger between Mylan NV and Pfizer Inc.’s Upjohn unit in 2020, has sold two of its businesses in India for $1.2 billion as part of a global exercise to exit non-core businesses. Viatris on Monday said it sold…